Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...

ER-300 improves key biomarkers of liver health in an animal model of MASH These data, along with additional ER-100 ...

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

Low blood sugar (hypoglycaemia) can occur even without diabetes. Learn about its causes, symptoms, risks, and when to seek ...

The National Health Service (NHS) in the UK has expanded its community liver health check programme through scanning trucks, ...

Thousands more people in England have been referred for liver cancer checks thanks to the expansion of an NHS scheme that ...

States along the Gulf Coast have raised alarms about a rise in infections from flesh-eating bacteria. In Louisiana, doctors ...

Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.

A married couple in Pune dies days apart following liver transplant surgery, prompting official investigation into medical ...

Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.